BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HRS-5765 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HRS-5765\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07551167-624@assetmemo.bio
DTSTAMP:20261121T005707Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:HRS-5765: Phase 1 readout est. (NCT07551167)
DESCRIPTION:HRS-5765\, phase 1\, Heart Failure.\nStudy: A Clinical Study of
  HRS-5765 in Healthy Participants\nEstimated primary completion: December 
 2026. This is a ClinicalTrials.gov estimate\, not a confirmed readout date
 \, and it can move.\nDrug page: https://assetmemo.bio/drug/hrs-5765#upcomi
 ng-events\nRegistry record: https://clinicaltrials.gov/study/NCT07551167
URL:https://assetmemo.bio/drug/hrs-5765#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
